Table 3.
Prevalence of the most common disorders at a grouped-level of diagnostic precision recorded in Boxers (n = 3,219) under primary veterinary care at UK practices participating in the VetCompass™ Programme from January 1st, 2016 to December 31st, 2016. Disorders with 50 or more events included
| Grouped-level Disordera | No | Overall prevalence % | 95% CI* | Median age (years) | Female prevalence % | Male prevalence % | Sex P-value** | White prevalence | Non-white prevalence | Colour P-value** |
|---|---|---|---|---|---|---|---|---|---|---|
| Skin disorder | 571 | 17.74 | 16.46–19.10 | 5.33 | 17.77 | 17.78 | 0.995 | 17.14 | 18.48 | 0.563 |
| Neoplasia | 457 | 14.20 | 13.03–15.45 | 8.15 | 14.85 | 13.45 | 0.256 | 15.24 | 14.32 | 0.663 |
| Ear disorder | 335 | 10.41 | 9.40–11.51 | 5.34 | 9.60 | 11.17 | 0.145 | 10.79 | 10.78 | 0.995 |
| Mass lesion | 325 | 10.10 | 9.10–11.19 | 8.75 | 11.87 | 8.47 | 0.001 | 9.52 | 10.55 | 0.573 |
| Ophthalmological disorder | 320 | 9.94 | 8.95–11.02 | 8.37 | 9.66 | 10.15 | 0.645 | 10.48 | 10.29 | 0.916 |
| Musculoskeletal disorder | 286 | 8.88 | 7.95–9.92 | 8.24 | 8.11 | 9.67 | 0.121 | 10.16 | 8.91 | 0.467 |
| Enteropathy | 250 | 7.77 | 6.89–8.74 | 3.86 | 7.26 | 8.23 | 0.308 | 9.84 | 7.81 | 0.210 |
| Heart disease | 204 | 6.34 | 5.55–7.23 | 7.93 | 5.51 | 7.09 | 0.067 | 6.35 | 6.44 | 0.952 |
| Nail disorder | 195 | 6.06 | 5.28–6.94 | 5.92 | 6.29 | 5.71 | 0.486 | 5.08 | 6.21 | 0.428 |
| Dental disorder | 170 | 5.28 | 4.56–6.11 | 8.64 | 6.16 | 4.44 | 0.030 | 7.94 | 5.14 | 0.039 |
| Urinary system disorder | 131 | 4.07 | 3.44–4.81 | 8.92 | 6.23 | 2.10 | < 0.001 | 4.13 | 4.15 | 0.983 |
| Obesity | 123 | 3.82 | 3.21–4.54 | 6.64 | 4.09 | 3.54 | 0.423 | 3.17 | 3.81 | 0.575 |
| Traumatic injury | 112 | 3.48 | 2.90–4.17 | 3.28 | 2.92 | 3.96 | 0.106 | 2.54 | 3.47 | 0.389 |
| Complication associated with clinical care procedure | 108 | 3.36 | 2.79–4.03 | 4.71 | 3.57 | 3.12 | 0.485 | 3.17 | 3.50 | 0.762 |
| Behavioural disorder | 106 | 3.29 | 2.73–3.97 | 5.96 | 2.08 | 4.44 | < 0.001 | 2.86 | 3.43 | 0.595 |
| Upper respiratory tract disorder | 104 | 3.23 | 2.67–3.90 | 4.22 | 2.85 | 3.60 | 0.231 | 4.13 | 3.12 | 0.341 |
| Female reproductive disorder | 83 | 2.58 | 2.08–3.19 | 4.55 | 5.32 | 0.06 | ~ | 1.90 | 2.70 | 0.401 |
| Brain disorder | 82 | 2.55 | 2.06–3.15 | 9.78 | 2.20 | 2.82 | 0.265 | 5.08 | 2.25 | 0.003 |
| Underweight | 71 | 2.21 | 1.75–2.77 | 3.11 | 2.14 | 2.28 | 0.784 | 3.49 | 2.02 | 0.090 |
| Anal sac disorder | 66 | 2.05 | 1.61–2.60 | 5.51 | 2.08 | 2.04 | 0.947 | 1.59 | 2.29 | 0.426 |
| Endocrine system disorder | 66 | 2.05 | 1.61–2.60 | 8.95 | 2.01 | 2.10 | 0.855 | 0.63 | 2.25 | 0.058 |
| Male reproductive system disorder | 56 | 1.74 | 1.34–2.25 | 4.65 | ~ | 3.36 | ~ | 2.86 | 1.68 | 0.137 |
aCI confidence interval. *The P-value reflects prevalence comparison between females and males. **The P-value reflects prevalence comparison between white and non-white Boxers